Have you been diagnosed with Smoldering Multiple Myeloma (SMM)? Are you 40 years old or older? If so, you may be able to participate in a study to see if AL-related genes can increase the chances of SMM patients developing AL Amyloidosis in the future.
Have you been diagnosed with metastatic breast cancer? If so, you may be able to take part in a research study looking at the safety and efficacy of giving a new drug called DB-1303 vs standard chemotherapy to patients with metastatic breast cancer.
This study aims to investigate the effectiveness and safety of retatrutide, a new diabetes medication) at doses of 4 mg, 9 mg, or 12 mg that will be taken as a weekly injection for about 1 year, compared to a placebo. A participant's change in HbA1c level will be primary outcome of interest. We are seeking participants with type 2 diabetes that has affected kidney function and are currently taking long-acting insulin with metformin and/or a SGLT2 inhibitor.
Do you smoke tobacco products? Participate in an eye-tracking research study and receive a $100 visa gift card.
Are you dealing with multiple myeloma that keeps coming back or hasn't improved? If you are, you may be able to join a study to see if a new drug called ABBV-383 could be safe and helpful for people in your situation. You will be reimbursed for travel expenses. You will not have to pay for the drug while you take part in this study.
To understand the views and perceptions of Ugandan social work academics who utilize decolonial and indigenous theories and practices, including ubuntu, in their work.
In this study, we want to see how learning a second language could change how you pronounce words in your first language. This will help us understand how sounds from different languages mix in our minds.
We are conducting interviews with members of the community to understand their perceptions related to mold in the home, and to capture any behaviors and concerns they have about mold.
Have you been diagnosed with Chronic Lymphocytic Leukemia (CLL) that has transformed to aggressive lymphoma called Richter's Transformation (RT)? Then you may be able to participate in this study whose purpose is to evaluate the efficacy and safety of glofitamab as monotherapy and in combination with polatuzumab vedotin or atezolizumab for participants with Richter's Transformation (RT) that has transformed from chronic lymphocytic leukemia (CLL). These are targeted immune-based therapies standardly used to treat lymphoma and/or other cancers that may also work well for RT
Are you experiencing symptoms of depression that have not been relieved by prescribed anti-depressant medication? If you have taken one or more prescribed anti-depressants and are still feeling symptoms of low mood, anxiety, sleep disruption, or appetite changes, you may be able to take part in a new medication trial for people who have not found other anti-depressants to help them. Compensation will be provided.